These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 11481031)
1. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect--a histopathological and immunohistochemical study. Nagtegaal ID; Marijnen CA; Kranenbarg EK; Mulder-Stapel A; Hermans J; van de Velde CJ; van Krieken JH BMC Cancer; 2001; 1():7. PubMed ID: 11481031 [TBL] [Abstract][Full Text] [Related]
2. Survival in rectal cancer is predicted by T cell infiltration of tumour-associated lymphoid nodules. McMullen TP; Lai R; Dabbagh L; Wallace TM; de Gara CJ Clin Exp Immunol; 2010 Jul; 161(1):81-8. PubMed ID: 20408858 [TBL] [Abstract][Full Text] [Related]
3. Epithelial human leukocyte antigen-DR expression predicts reduced recurrence rates and prolonged survival in rectal cancer patients. de Bruin EC; van de Velde CJ; van Krieken JH; Marijnen CA; Medema JP Clin Cancer Res; 2008 Feb; 14(4):1073-9. PubMed ID: 18281539 [TBL] [Abstract][Full Text] [Related]
4. Prognostic and predictive values of the immunoscore in patients with rectal cancer. Anitei MG; Zeitoun G; Mlecnik B; Marliot F; Haicheur N; Todosi AM; Kirilovsky A; Lagorce C; Bindea G; Ferariu D; Danciu M; Bruneval P; Scripcariu V; Chevallier JM; Zinzindohoué F; Berger A; Galon J; Pagès F Clin Cancer Res; 2014 Apr; 20(7):1891-9. PubMed ID: 24691640 [TBL] [Abstract][Full Text] [Related]
5. Corelation of lymphocytic infiltrates with the prognosis of recurrent colo-rectal cancer. Makkai-Popa ST; Luncă S; Dimofte G; Vrânceanu A; Franciug D; Ivanov I; Zugun F; Târcoveanu E; Carasevici E Chirurgia (Bucur); 2013; 108(6):859-65. PubMed ID: 24331327 [TBL] [Abstract][Full Text] [Related]
6. The clinical utility of the local inflammatory response in colorectal cancer. Richards CH; Roxburgh CS; Powell AG; Foulis AK; Horgan PG; McMillan DC Eur J Cancer; 2014 Jan; 50(2):309-19. PubMed ID: 24103145 [TBL] [Abstract][Full Text] [Related]
7. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer. Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of EpCAM-positive disseminated tumor cells in rectal cancer patients with stage I disease. Dhayat S; Sorescu S; Vallböhmer D; Kraus S; Baldus SE; Rehders A; Kröpil F; Krieg A; Knoefel WT; Stoecklein NH Am J Surg Pathol; 2012 Dec; 36(12):1809-16. PubMed ID: 23060348 [TBL] [Abstract][Full Text] [Related]
9. Implication of programmed cell death ligand 1 expression in tumor recurrence and prognosis in rectal cancer with neoadjuvant chemoradiotherapy. Saigusa S; Toiyama Y; Tanaka K; Inoue Y; Mori K; Ide S; Imaoka H; Kawamura M; Mohri Y; Kusunoki M Int J Clin Oncol; 2016 Oct; 21(5):946-952. PubMed ID: 26919982 [TBL] [Abstract][Full Text] [Related]
10. Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer. Peng J; Lu JJ; Zhu J; Xu Y; Lu H; Lian P; Cai G; Cai S Cancer J; 2008; 14(1):54-61. PubMed ID: 18303484 [TBL] [Abstract][Full Text] [Related]
11. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Horn A; Dahl O; Morild I Dis Colon Rectum; 1991 Sep; 34(9):798-804. PubMed ID: 1914747 [TBL] [Abstract][Full Text] [Related]
12. Rsf-1 expression in rectal cancer: with special emphasis on the independent prognostic value after neoadjuvant chemoradiation. Lin CY; Tian YF; Wu LC; Chen LT; Lin LC; Hsing CH; Lee SW; Sheu MJ; Lee HH; Wang YH; Shiue YL; Wu WR; Huang HY; Hsu HP; Li CF; Chen SH J Clin Pathol; 2012 Aug; 65(8):687-92. PubMed ID: 22569540 [TBL] [Abstract][Full Text] [Related]
13. Molecular markers predict distant metastases after adjuvant chemoradiation for rectal cancer. Kim JW; Kim YB; Choi JJ; Koom WS; Kim H; Kim NK; Ahn JB; Lee I; Cho JH; Keum KC Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e577-84. PubMed ID: 22981710 [TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic and prognostic significance of matrix metalloproteinases in rectal cancer. Schwandner O; Schlamp A; Broll R; Bruch HP Int J Colorectal Dis; 2007 Feb; 22(2):127-36. PubMed ID: 16896992 [TBL] [Abstract][Full Text] [Related]
15. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Roxburgh CS; McMillan DC Cancer Treat Rev; 2012 Aug; 38(5):451-66. PubMed ID: 21945823 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Immune Cells Subsets Within the Tumor Microenvironment in Patients With Rectal Adenocarcinoma. Ke TW; Zwane ST; Chiang SF; Chen TW; Yang PC; Chen LC; Lin YS; Chen WT; Chao KSC; Huang KC Anticancer Res; 2024 Feb; 44(2):787-796. PubMed ID: 38307574 [TBL] [Abstract][Full Text] [Related]
18. Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis. Yao YF; Du CZ; Chen N; Chen P; Gu J Dis Colon Rectum; 2014 May; 57(5):602-7. PubMed ID: 24819100 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of CD4+ and CD8+ T cell infiltration within cancer cell nests in vulvar squamous cell carcinoma. Sznurkowski JJ; Zawrocki A; Emerich J; Biernat W Int J Gynecol Cancer; 2011 May; 21(4):717-21. PubMed ID: 21543933 [TBL] [Abstract][Full Text] [Related]
20. Ovine cutaneous squamous cell carcinoma: immunohistochemical expression of CD3, CD4, CD8 and MHC class II antigens in the associated inflammatory infiltrate. Mozos E; Méndez A; Martín MP; Herráez P; Pérez J Vet Immunol Immunopathol; 1998 Feb; 61(2-4):221-8. PubMed ID: 9613436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]